AMAR

Amar Remedies Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Members of the Company held on September 30, 2010.

Amar Remedies Limited has informed the Exchange that the meeting of Board of Directors held on August 28, 2010 transacted the following business: a) To convene the Annual General Meeting of the Company for the year ended June 30, 2010 on September 30, 2010. (b) To close the Register of Members from September 23, 2010 to September 30, 2010 for the purpose of Annual General Meeting and Dividend declaration.

Amar Remedies Limited has informed the Exchange that Board of Directors in its meeting held on August 28, 2010 has recommended dividend of Re.1/- per share (@10%) on fully paid Equity Shares of Rs.10/- each of the company for the financial year ended June 30, 2010.

Amar Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on June 22, 2010, appointed Mrs. Preeti Balwantrai Desai and Mr. Jyotirmay Prakash Varma as an Additional Director of the Company w.e.f June 22, 2010.

Amar Remedies Limited has submitted to the Exchange a copy of results of the voting conducted through postal ballot on resolutions as per notice dated April 24, 2010.

Amar Remedies Limited has informed the Exchange that pursuant to section 192A(2) of the Companies Act, 1956, read with the Companies (Passing of Resolution by Postal Ballot) Rules 2001, the Company is seeking the consent of its members in respect of the special Business proposed to be obtained by means of Postal Ballot instead of transacting such businesses in General Meeting of the Company.

Amar Remedies Limited has informed the Exchange that the Board of Directors has accorded their approval to the following items at the Board Meeting held on April 24, 2010, (1) To raise an additional funds by way of issue of FCCB/GDR/QIP/NCD/CCD to the extent of $60 million ($ Sixty million only) (2) To increase the Authorised Share Capital of the Company from existing Rs. 28 Crores (Rupees Twenty Eight Crores) to Rs. 50 Crores (Rupees Fifty Crores Only) (3) To approve the Employees Stock Option Scheme (ESOS) under which options carrying right to acquire up to 10 lacs (Ten Lacs Only) Equity Sha

Amar Remedies Limited has informed the Exchange that the Board of Directors at its meeting held on March 31, 2010, reappointed Mr. Sagar P. Shah as Managing Director of the Company for the period of 5 years w.e.f. April 01, 2010.

Amar Remedies Limited has informed the Exchange regarding the outcome of Annual General Meeting held on December 26, 2009.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/AMAR_outcomeofagm_28122009.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has informed the Exchange that the Board has accorded their approval to the following items at the Board Meeting held on November 23, 2009: (1) To convene the Annual General Meeting of the Company for the year ended June 30, 2009 on December 26, 2009. (2) To close the register of members from December 19, 2009 to December 26, 2009 for the purpose of Annual General Meeting and Dividend declaration.

Amar Remedies Limited has informed the Exchange that the Board of Directors at their meeting held on November 23, 2009, the board has not considered issuing Pref. issue of Equity Shares / Warrants to the promoters at present and deferred its decision on the same at a future date.

Amar Remedies Limited has informed the Exchange that the meeting of Board of Directors of the Company held on September 30, 2009, has recommends dividend @10% (Rs.1 per share) on fully paid Equity Shares of Rs.10 each of the Company for the financial year ended June 30, 2009.

Amar Remedies Limited has informed the Exchange that "Our Company's financial year ending is June 2009 we intend to provide audited results within a period of 3 months from the end of last quarter of the financial year, hence we would not be providing/publishing unaudited result for the last quarter ended 30.06.2009 to Stock Exchange/s".

Amar Remedies Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on April 29, 2009 have approved the Resignation of Mr. Bhagwansingh G. Chaudhary from the directorship of the company with immediate effect.

Amar Remedies Limited has submitted to the Exchange a disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers)(Amendment) Regulations, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/amar_regulation_23042009.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has submitted to the Exchange a disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers)(Amendment) Regulations, 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/amarremedies_Reg_13022009.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has informed the Exchange that "The Company at the Annual General Meeting (AGM) of Members held on 5th December, 2008, could take up the Item no.1 of the Notice calling AGM for vote by show of hands, one shareholder holding requisite no. of shares demanded poll for all the items of business mentioned in the Notice. Poll was carried out and all the resolutions were passed by majority as set out in Notice calling AGM. Result of the Poll: Total votes received 11300986 (100%). Votes cast in favour 11293186 (99.93%). Votes cast against 7800 (0.07%). The details of resolutions

Amar Remedies Limited has informed the Exchange that the Company has fixed Book Closure from November 28, 2008 to December 05, 2008 for the purpose of AGM.

Amar Remedies Limited has informed the Exchange that the Board has accorded approval to the following items at the Board Meeting held on October 30, 2008: 1) To Issue 13,00,000 Equity Shares on Preferential Basis to Shri Sagar P. Shah, Promoter/ Managing Director of the Company. 2) To convene the Annual General Meeting of the Company for the year ended June 30, 2008 on December 05, 2008.

Amar Remedies Limited has submitted to the Exchange a Statement of Appropriations for the year ended June 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Amar_Appropriations_01102008.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has informed the Exchange that : "Our Company's financial year ending is June 2008 we intended to provide audited results within a period of 3 months from the end of last quarter of the financial year, hence we would not be providing/ publishing unaudited result for the last quarter ended 30.06.2008 to Stock Exchange/s".

Amar Remedies Limited has informed the Exchange that: "Meeting of board of directors was held on July 10, 2008 in which Mr. Rajiv Mukundrao Chitnis Director of the Company has been appointed as Whole time Director designated as Executive Director for the period of 3 years w.e.f. July 10, 2008. Further, Mr Rajiv Mukundrao Chitnis Whole Time Director of the Company has been appointed as compliance officer of the company".

Amar Remedies Limited has informed the Exchange that "The Company's wholly owned subsidiary has been formed at Ras-AL-Khaimah-Free Trade Zone, United Arab Emirates for carrying on general trading business of toothpaste, toothpowder & balm etc."

Amar Remedies Limited has informed the Exchange that "Board of Directors of the company at their meeting held on 14th December 2007 has decided to form a wholly owned subsidiary of the company at Ras-AL-Khaimah-Free Trade Zone, UAE".

Amar Remedies Limited has informed the Exchange regarding the Outcome of the Annual General Meeting held on November 15, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Amar_AGM_15112007.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has informed the Exchange that the company has announced Book Closure from November 07, 2007 to November 15, 2007 for the purpose of Annual General Meeting to be held on November 15, 2007.

Amar Remedies Limited has informed the Exchange vide its letter dated October 04, 2007 that Shri Hemal Shah has been ceased to be Director as well as Whole Time Director of the company with effect from October 02, 2007, due to Resignation tendered by him from the post of Directorship of the Company.

Amar Remedies Limited has submitted to the Exchange a copy of the Statement of Appropriations for the year ended June 30, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/AMAR_APPROPRIATION_03102007.zip target=NEW> For more details click here.</a>

Amar Remedies Limited has informed the Exchange that: "Mr. Yusuf Iqbal Yusuf has been appointed as an additional director of the company w.e.f 30th August 2007".

Amar Remedies Limited has informed the Exchange that the Company shall publish Audited Financial Results within a period of 3 month for the year ended on June 30, 2007 i.e. on or before September 30, 2007.

Amar Remedies Limited has informed the Exchange that we have designated investors@amarremedies.com for the purpose of registering complaints by the investors.

Amar Remedies Limited has informed the Exchange that "Shri Lalit Chandra Vaidya has been ceased to be director of the company due to Dead."

Amar Remedies Limited has informed the Exchange that "the company has changed its Registered office of the company from existing to: Sane Guruji Premises, Block No 3, 2nd Floors, 386, S.V. Savarkar Marg, Opp. Siddhivinayak Temple, Prabhadevi, Mumbai 400025. Kindly also note the our new contact nos: Board : (022) 30409100, Fax : (022) 30409120/21, Email :hemalshah@amarremedies.com, ipo@amarremedies.com".

Amar Remedies Limited has informed the Exchange that the members at the Annual General Meeting (AGM) of the Company held on October 27, 2006 have accorded approval to the following:- (a) Re-appointment of Mr. Dilip S Mehta, as Director of the Company, liable to retire by rotation. (b) Re-appointment of Mr. P Shah, as Director of the Company, liable to retire by rotation. (c) Re-appointment of Mrs. Pratima P Shah, as Director of the Company, liable to retire by rotation. (d) Re-appointment of M/s. Shyam C Agarwal & Co., Chartered Accountants, as Auditors of the Company to hold office until the

Amar Remedies Limited has informed the Exchange that the company has received ISO 9001:2000 Certificate of compliance from International certification Services (Asia) Pvt. Ltd. on September 30,2006 for the company's Quality Management System (QMS) for the scope of development, Manufacturing and supply of Toothpastes, toothpowders and relieving balms.

Amar Remedies Limited has informed the Exchange that the company has announced Book Closure from October 20,2006 to October 27,2006 for the purpose of AGM.

Amar Remedies Limited has informed the Exchange regarding the utilisation of funds from public issue proceedings of Rs.42 crores as on June 30,2006 which is as follows: 1) Public Issue Exps. : 465.25 (Rs. in lacs); 2) Working Capital Repayment/Utilisation : 1560.00 (Rs. in lacs); 3) Spent for Surat Plant : 598.43 (Rs. in lacs); 4) Research & Development / Analytical Laboratory : 196.25 (Rs. in lacs); 5) Marketing/Branding / Sales promotion : 551.92 (Rs. in lacs); 6) Investment in Inter Corporate Deposits : 540.35 (Rs. in lacs); 7) General Corporate Purpose : 287.80 (Rs. in lacs). Total: 4200.

Amar Remedies Limited has informed the Exchange regarding the result of the voting conducted through Postal Ballot on the Resolutions as per the Postal Notice dated August 09, 2006, relating to items of Business as mentioned in the said notice. Number of valid postal ballot forms received : 1062. Number of invalid postal ballot forms received : 60. (I) Subject Matter of Resolution - Increasing investment of foreign institutional investor (FII) in the Equity Capital of the Company from 24% to 45%. Ordinary / Special Resolution - Special. Votes in favour of the Resolution - 11486713. Votes again

Amar Remedies Limited has informed the Exchange that at the Board of Directors meeting held on September 23, 2006, the following decisions were made: (1) Annual General Meeting will be held on October 27, 2006.(2) Work at Dehradun plant is in full progress and company expect to start commercial production from January, 2007.(3) Work at Surat plant is in completion stage and commercial production will start from October 2, 2006.

Amar Remedies Limited has informed the Exchange that the Board of Directors in their Meeting held on August 09, 2006 have decided to increase investment of FII limit in the Equity capital of the company from 24% to 45% and the approval of members of the Company be obtained through postal ballot.

Amar Remedies Limited has informed the Exchange that the Company's financial year ending is July, 2005- June 2006, the Company intend to provide audited results within a period of 3 months from the end of the last quarter of the financial year, hence the Company would not be providing / publishing unaudited results for the last quarter ended June 30, 2006 to the Stock Exchange /s.

Amar Remedies Limited has informed the Exchange that Lotus Global Investments Ltd. has sold 1,00,000 shares aggregating to 0.362% of the total share capital of Amar Remedies Limited on March 17, 2006. The shareholding of Lotus Global Investments Ltd. after the said sale is 960,000 shares aggregating to 3.669% of the share capital of Amar Remedies Limited.

Lotus Global Investments Ltd. has informed the Exchange that they have sold 1,00,000 shares aggregating to 0.362% of the total share capital of Amar Remedies Limited as intimated to the Company on March 17, 2006. The shareholding of Lotus Global Investments Ltd. after the said sale is 960,000 shares aggregating to 3.669% of the share capital of Amar Remedies Limited.

Amar Remedies Limited has informed the Exchange that Bear, Stearns & Co. A/C BSMA Ltd. has acquired 10,00,000 shares aggregating to 3.82% of the total share capital of Amar Remedies Limited on March 08, 2006. The mode of acquisition is through Secondary Market and the shareholding of Bear, Stearns & Co. A/C BSMA Ltd. after the said acquisition is 17,61,000 shares aggregating to 6.73% of the total share capital of Amar Remedies Limited.

Citibank, N. A., has informed the Exchange that Bear Stearns & Co. A/c BSMA Limited has acquired 10,00,000 shares aggregating to 3.822% of the total paid up capital of Amar Remedies Ltd. on March 06, 2006. The mode of acquisition is through Secondary Market Purchase and the shareholding of Bear Stearns & Co. A/c BSMA Limited after the said acquisition is 17,61,000 shares aggregating to 6.731% of the total paid up capital of Amar Remedies Ltd..

Charlemagne Capital (IOM) Limited on behalf of Magna India Fund has informed the Exchange that they have acquired 390,171 shares of Amar Remedies Ltd. and the shareholding of Charlemagne Capital (IOM) Limited on behalf of Magna India Fund after the said acquisition is 1,465,363 shares aggregating to 5.60% of the total paid up capital of Amar Remedies Ltd.

Amar Remedies Limited has informed the Exchange that the BODs meeting to be convened on October 07, 2005 to consider and approve setting up of an additional manufacturing facility at Deharadun, to manufacture toothpaste and few Ayurvedic products, at the same time to assess situation of Surat project for implementation, has been postponed. The Company shall inform the next date at a later stage.